Hillhouse Capital Advisors as of Dec. 31, 2018
Portfolio Holdings for Hillhouse Capital Advisors
Hillhouse Capital Advisors holds 32 positions in its portfolio as reported in the December 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Beigene (BGNE) | 25.8 | $623M | 4.4M | 140.26 | |
Jd (JD) | 13.1 | $315M | 15M | 20.93 | |
China Biologic Products | 8.7 | $209M | 2.8M | 75.91 | |
TAL Education (TAL) | 8.3 | $200M | 7.5M | 26.68 | |
Alibaba Group Holding (BABA) | 8.0 | $194M | 1.4M | 137.07 | |
Mondelez Int (MDLZ) | 5.9 | $141M | 3.5M | 40.03 | |
Fibrogen (FGEN) | 3.9 | $93M | 2.0M | 46.28 | |
58 Com Inc spon adr rep a | 3.3 | $81M | 1.5M | 54.21 | |
Blueprint Medicines (BPMC) | 3.2 | $77M | 1.4M | 53.91 | |
Ikang Healthcare Group- | 2.5 | $60M | 2.9M | 20.38 | |
Myokardia | 1.7 | $42M | 858k | 48.86 | |
Line Corp- | 1.7 | $41M | 1.2M | 34.11 | |
Kiniksa Pharmaceuticals (KNSA) | 1.6 | $39M | 1.4M | 28.09 | |
Pinduoduo (PDD) | 1.6 | $39M | 1.7M | 22.44 | |
Snap Inc cl a (SNAP) | 1.6 | $38M | 6.9M | 5.51 | |
Bright Scholar Ed Hldgs | 1.5 | $37M | 4.0M | 9.21 | |
Bilibili Ads (BILI) | 1.3 | $32M | 2.2M | 14.59 | |
Apellis Pharmaceuticals (APLS) | 1.2 | $29M | 2.2M | 13.19 | |
Tencent Music Entertco L spon ad (TME) | 0.8 | $19M | 1.5M | 13.22 | |
Loxo Oncology | 0.8 | $18M | 131k | 140.07 | |
G1 Therapeutics (GTHX) | 0.8 | $18M | 949k | 19.15 | |
Iqiyi (IQ) | 0.7 | $17M | 1.1M | 14.87 | |
Sohu (SOHU) | 0.6 | $14M | 802k | 17.42 | |
REPCOM cla | 0.5 | $12M | 194k | 59.86 | |
Arvinas Ord (ARVN) | 0.3 | $8.0M | 625k | 12.85 | |
Arcus Biosciences Incorporated (RCUS) | 0.2 | $4.6M | 425k | 10.77 | |
Proteostasis Therapeutics In | 0.1 | $2.8M | 866k | 3.24 | |
Puxin Ltd ads | 0.1 | $2.9M | 490k | 5.91 | |
Eidos Therapeutics | 0.1 | $2.5M | 179k | 13.76 | |
Fang Hldgs | 0.1 | $2.1M | 1.5M | 1.43 | |
Neon Therapeutics | 0.1 | $1.6M | 313k | 5.03 | |
Melco Crown Entertainment (MLCO) | 0.0 | $455k | 26k | 17.63 |